Analyze Diet
Equine veterinary journal2020; 53(5); 923-934; doi: 10.1111/evj.13378

Equine metabolic syndrome in UK native ponies and cobs is highly prevalent with modifiable risk factors.

Abstract: The epidemiology of equine metabolic syndrome (EMS) is poorly described. Objective: To estimate the prevalence of EMS in native UK ponies and cobs in England and Wales and identify associated risk factors. Methods: Cross-sectional study. Methods: Breeders registered with UK native pony breed societies and registered riding schools and livery yards within a set radius were invited to participate. All native UK ponies and cobs aged 3-14 years and not diagnosed or being treated for conditions likely to affect insulin regulation at participating premises were eligible. Animals underwent a clinical examination and an oral glucose test while their owner or keeper completed a questionnaire by face-to-face interview. Data were analysed by multilevel uni- and multivariable modelling using insulin concentration and EMS diagnosis as outcomes. Results: A total of 354 animals were examined at 64 properties (19 studs, 19 livery yards, 26 riding schools). The overall prevalence of EMS adjusted for clustering within yard was 23.3% (95%CI 17.9%-29.8%). Risk factors associated with a diagnosis of EMS included age, being female, more sedentary main activity, obesity, and shorter periods on pasture during the summer. Compared to the Welsh section A, the other Welsh, Connemara and cob breeds all had decreased odds of EMS. Clinical manifestations of hoof growth ring and supraorbital fat scores of 3/3 were more frequent in EMS ponies and animals with a history of laminitis within the last 5 years (9.7%) were 14.4 (95% CI 5.9-35.3) times more likely to be positive for EMS than those without. Conclusions: Results may not be transferable to other breeds or age groups. Conclusions: Equine metabolic syndrome is highly prevalent in UK native ponies and cobs with modifiable risk factors including obesity and sedentary activities. Modifying risk factors could help reduce the risk of laminitis in susceptible animals.
Publication Date: 2020-12-03 PubMed ID: 33128277PubMed Central: PMC8451835DOI: 10.1111/evj.13378Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research aimed to determine the prevalence of equine metabolic syndrome (EMS) in native UK ponies and cobs and identify potential associated risk factors. The study found that EMS is common in these animals, with factors such as age, gender, lifestyle, and obesity contributing to the likelihood of diagnosis.

Research Methodology

  • The study employed a cross-sectional design. The participants of the research were breeders registered with UK native pony breed societies, and registered riding schools and livery yards within a predetermined radius.
  • The study focused on native UK ponies and cobs between the ages of 3 and 14 who were not diagnosed with or being treated for conditions likely to affect insulin regulation.
  • Data was collected through a clinical examination of the animals, an oral glucose test, and a questionnaire completed by the animal’s owner or keeper. The answers were given through an interview.
  • The analysis was performed by multilevel uni- and multivariable modelling, with insulin concentration and EMS diagnosis as the outcomes.

Findings

  • A total of 354 animals from 64 properties (19 studs, 19 livery yards, 26 riding schools) were examined. The study found an overall prevalence of EMS of 23.3% after adjusting for clustering within yards.
  • Associated risk factors for an EMS diagnosis were age, being female, a more sedentary main activity, obesity, and shorter periods of time spent on pasture during the summer.
  • Compared to the Welsh section A, the Connemara and cob breeds all had decreased odds of EMS.
  • Ponies and cobs with EMS more frequently exhibited clinical manifestations of hoof growth ring and a supraorbital fat score of 3/3.
  • Animals with a history of laminitis within the last 5 years were 14.4 times more likely to test positive for EMS than those without.

Limits of Findings

  • It is noted that these results may not be transferable to other breeds or age groups. Further research would be necessary to determine if these findings hold true across different pony and cob groups.

Conclusion

  • EMS is highly prevalent in UK native ponies and cobs. Notably, several of the risk factors associated with the syndrome are modifiable. This suggests that changes in areas such as animals’ weight and activity levels may help reduce the risk of EMS and related conditions such as laminitis.

Cite This Article

APA
Carslake HB, Pinchbeck GL, McGowan CM. (2020). Equine metabolic syndrome in UK native ponies and cobs is highly prevalent with modifiable risk factors. Equine Vet J, 53(5), 923-934. https://doi.org/10.1111/evj.13378

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 53
Issue: 5
Pages: 923-934

Researcher Affiliations

Carslake, Harry B
  • Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Leahurst, UK.
Pinchbeck, Gina L
  • Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Leahurst, UK.
McGowan, Catherine M
  • Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Leahurst, UK.

MeSH Terms

  • Animals
  • Cross-Sectional Studies
  • Female
  • Foot Diseases / veterinary
  • Horse Diseases / epidemiology
  • Horse Diseases / etiology
  • Horses
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / veterinary
  • Risk Factors
  • United Kingdom / epidemiology

Grant Funding

  • University of Liverpool
  • Boehringer Ingelheim

Conflict of Interest Statement

No competing interests have been declared.

References

This article includes 38 references
  1. Durham AE, Frank N, McGowan CM, Menzies‐Gow NJ, Roelfsema E, Vervuert I. ECEIM consensus statement on equine metabolic syndrome.. J Vet Intern Med 2019;33:335–49.
    pmc: PMC6430910pubmed: 30724412
  2. Carter RA, Treiber KH, Geor RJ, Douglass L, Harris PA. Prediction of incipient pasture‐associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies.. Equine Vet J 2009;41:171–8.
    pubmed: 19418747
  3. Menzies‐Gow NJ, Harris PA, Elliott J. Prospective cohort study evaluating risk factors for the development of pasture‐associated laminitis in the United Kingdom.. Equine Vet J 2017;49:300–6.
    pubmed: 27363591
  4. Treiber KH, Kronfeld DS, Hess TM, Boston RC, Harris PA. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta‐cell responsiveness in horses.. Am J Vet Research 2005;66:2114–21.
    pubmed: 16379656
  5. Morgan RA, Keen JA, McGowan CM. Treatment of equine metabolic syndrome: A clinical case series.. Equine Vet J 2016;48:422–6.
    pubmed: 25808563
  6. Kronfeld DS, Treiber KH, Geor RJ. Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies.. J Am Vet Med Assoc 2005;226:712–9.
    pubmed: 15776943
  7. Pollard D, Wylie CE, Verheyen KLP, Newton JR. Identification of modifiable factors associated with owner‐reported equine laminitis in Britain using a web‐based cohort study approach.. BMC Vet Res 2019;15:59.
    pmc: PMC6373032pubmed: 30755193
  8. Wylie CE, Collins SN, Verheyen KL, Richard Newton J. Frequency of equine laminitis: a systematic review with quality appraisal of published evidence.. Vet J 2011;189:248–56.
    pubmed: 21665498
  9. Robin CA, Ireland JL, Wylie CE, Collins SN, Verheyen KL, Newton JR. Prevalence of and risk factors for equine obesity in Great Britain based on owner‐reported body condition scores.. Equine Vet J 2015;47:196–201.
    pubmed: 24735219
  10. Morgan RA, McGowan TW, McGowan CM. Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia.. Aust Vet J 2014;92:101–6.
    pubmed: 24673135
  11. Bamford NJ, Potter SJ, Harris PA, Bailey SR. Breed differences in insulin sensitivity and insulinemic responses to oral glucose in horses and ponies of moderate body condition score.. Domest Anim Endocrinol 2014;47:101–7.
    pubmed: 24308928
  12. Norton EM, Schultz NE, Rendahl AK, McFarlane D, Geor RJ, Mickelson JR. Heritability of metabolic traits associated with equine metabolic syndrome in Welsh ponies and Morgan horses.. Equine Vet J 2019;51:475–80.
    pubmed: 30472742
  13. Pleasant RS, Suagee JK, Thatcher CD, Elvinger F, Geor RJ. Adiposity, plasma insulin, leptin, lipids, and oxidative stress in mature light breed horses.. J Vet Intern Med 2013;27:576–82.
    pubmed: 23517373
  14. Carroll CL, Huntington PJ. Body condition scoring and weight estimation of horses.. Equine Vet J 1988;20:41–5.
    pubmed: 3366105
  15. Kohnke J. Feeding and Nutrition: The Making of a Champion.. Australia: Birubi Pacific; 1992.
  16. Carter RA, Geor RJ, Burton Staniar W, Cubitt TA, Harris PA. Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies.. Vet J 2009;179:204–10.
    pubmed: 18440844
  17. Carslake HB, Pinchbeck GL, McGowan CM. Evaluation of a Chemiluminescent Immunoassay for Measurement of Equine Insulin.. J Vet Intern Med 2017;31:568–74.
    pmc: PMC5354037pubmed: 28124389
  18. Perkins GA, Lamb S, Erb HN, Schanbacher B, Nydam DV, Divers TJ. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide.. Equine Vet J 2002;34:679–85.
    pubmed: 12455838
  19. Hackett ES, McCue PM. Evaluation of a veterinary glucometer for use in horses.. J Vet Intern Med 2010;24:617–21.
    pubmed: 20337908
  20. de Laat MA, Sillence MN. The repeatability of an oral glucose test in ponies.. Equine Vet J 2017;49:238–43.
    pubmed: 27038020
  21. Schott HC, Andrews FM, Durham A, Frank N, Hart KA, Kritchevsky J. Recommendations for the Diagnosis and Treatment of PPID.. 2019.
  22. Rasbach J, Steele F, Browne WK, Goldstein H. A User's Guide to MLwiN, v3.01, Centre for Multilevel Modelling.. University of Bristol; 2017.
  23. Hosmer DW, Lemeshow S. Model‐building strategies and methods for logistic regression.. In: Cressie NAC, Fisher NI, Johnstone IM. Applied Logistic Regression (2nd edn, pp 91–142). New York: John Wiley & Sons; 2005.
  24. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ, College A. Equine metabolic syndrome.. J Vet Intern Med 2010;24:467–75.
    pubmed: 20384947
  25. Meier AD, de Laat MA, Reiche DB, Pollitt CC, Walsh DM, McGree JM. The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates.. Domest Anim Endocrinol 2017;63:1–9.
    pubmed: 29172109
  26. Karikoski NP, McGowan CM, Singer ER, Asplin KE, Tulamo RM, Patterson‐Kane JC. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.. Vet Pathol 2015;52:945–56.
    pubmed: 25232034
  27. Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function.. Diabetes 2010;59:89–97.
    pmc: PMC2797949pubmed: 19833885
  28. Vick MM, Adams AA, Murphy BA, Sessions DR, Horohov DW, Cook RF. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse.. J Anim Sci 2007;85:1144–55.
    pubmed: 17264235
  29. Fitzgerald DM, Anderson ST, Sillence MN, de Laat MA. The cresty neck score is an independent predictor of insulin dysregulation in ponies.. PLoS One 2019;14:e0220203.
    pmc: PMC6655749pubmed: 31339945
  30. Bamford NJ, Potter SJ, Baskerville CL, Harris PA, Bailey SR. Effect of increased adiposity on insulin sensitivity and adipokine concentrations in different equine breeds adapted to cereal‐rich or fat‐rich meals.. Vet J 2016;214:14–20.
    pubmed: 27387720
  31. Dugdale AH, Grove‐White D, Curtis GC, Harris PA, Argo CM. Body condition scoring as a predictor of body fat in horses and ponies.. Vet J 2012;194:173–8.
    pubmed: 22578691
  32. Norton EM, Avila F, Schultz NE, Mickelson JR, Geor RJ, McCue ME. Evaluation of an HMGA2 variant for pleiotropic effects on height and metabolic traits in ponies.. J Vet Intern Med 2019;33:942–52.
    pmc: PMC6430908pubmed: 30666754
  33. Godsland IF. Oestrogens and insulin secretion.. Diabetologia 2005;48:2213–20.
    pubmed: 16193292
  34. Caughey AB, Turrentine M. ACOG Practice Bulletin No. 190 Summary: Gestational Diabetes Mellitus.. Obstet Gynecol 2018;131:406–8.
    pubmed: 29370044
  35. Beythien E, Wulf M, Ille N, Aurich J, Aurich C. Effects of sex, pregnancy and season on insulin secretion and carbohydrate metabolism in horses.. Anim Reprod Sci 2017;184:86–93.
    pubmed: 28701287
  36. Bamford NJ, Potter SJ, Baskerville CL, Harris PA, Bailey SR. Influence of dietary restriction and low‐intensity exercise on weight loss and insulin sensitivity in obese equids.. J Vet Intern Med 2019;33:280–6.
    pmc: PMC6335535pubmed: 30520164
  37. Morgan K. Thermoneutral Zone and Critical Temperatures of Horses.. J Therm Biol 1998;23:59–61.
  38. Met Office. Northwest England and Isle of Man: Climate.. 2016.